LIC has raised its stake in Sun Pharmaceutical Industries to above 5%, reflecting confidence in the company's growth potential.

Target Information

The Life Insurance Corporation of India (LIC), recognized as the largest institutional investor in the country, has increased its stake in Sun Pharmaceutical Industries to over 5%. This acquisition was disclosed in an exchange filing dated January 14, 2026. On January 13, LIC purchased 202,500 shares in the open market, resulting in a 0.008% increase in its ownership. Following this transaction, LIC's total stake in Sun Pharma grew to 5.004%, compared to its previous holding of 4.996%.

Prior to this transaction, LIC held approximately 10.12 crore shares, representing a 4.22% stake in Sun Pharma at the end of the September quarter. The company's shareholding pattern for the December quarter is pending disclosure. At the conclusion of Q2 FY26, promoters maintained a 54.48% holding in the firm.

Industry Overview in India

The pharmaceutical industry in India has seen significant growth, propelled by increasing healthcare demands and an expanding patient base. With a population exceeding 1.4 billion, India remains a critical market for pharmaceutical c